+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Screening for symptoms of depression and anxiety in adolescents and young adults with cystic fibrosis



Screening for symptoms of depression and anxiety in adolescents and young adults with cystic fibrosis



Pediatric Pulmonology 46(2): 153-159



Although studies have assessed symptoms of depression and anxiety in individuals with cystic fibrosis (CF), few have been conducted since the advent of new medical treatments (e.g., nebulized antibiotics, ThAIRpy Vest). Study objectives were to: (1) document symptoms of depression and anxiety for adolescents and young adults with CF and compare with normative values, (2) examine the associations among depressive/anxiety symptoms and gender, age, lung function, and body mass index, and (3) determine the relations between adolescent and caregiver symptoms of depression and anxiety. Patients and caregivers completed the Hospital Anxiety and Depression Scale (HADS) anytime (e.g., beginning or end) during routine CF clinic appointments. Participants included 59 adolescents/young adults with CF (M(age)  = 15.8 years, 54% female, 98% Caucasian, M(FEV1% predicted)  = 84.6) and caregivers of 40 adolescents. Although symptom scores were in the normative range for patients with CF (M(Depression)  = 2.27 and M(Anxiety)  = 5.59), 3% and 32% exhibited clinically elevated symptoms of depression and anxiety, respectively. Symptoms of depression and anxiety were significantly associated with age (r = 0.28, 0.36). Symptoms of depression and anxiety were also positively correlated (r = 0.48). Females endorsed higher anxiety symptoms than males. While adolescent and caregiver anxiety scores were not related, higher caregiver depressive symptoms were associated with older patient age and worse lung function. Data from the current study suggest low levels of depressive symptoms and substantial levels of anxiety symptoms in adolescents and young adults with CF. Consistent with prior literature, depressive symptoms appear higher in older patients and are significantly associated with anxiety symptoms. Caregiver symptomology appears to be more affected by an adolescent's health status, suggesting a need to screen caregivers when health begins to decline.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 055672636

Download citation: RISBibTeXText

PMID: 21259449

DOI: 10.1002/ppul.21334


Related references

Prevalence of symptoms of depression and anxiety in adults with cystic fibrosis based on the PHQ-9 and GAD-7 screening questionnaires. Psychosomatics 56(4): 345-353, 2016

Examining the Stability of the Hospital Anxiety and Depression Scale Factor Structure in Adolescents and Young Adults With Cystic Fibrosis: A Confirmatory Factor Analysis. Journal of Pediatric Psychology 43(6): 625-635, 2018

Prevalence of Symptoms of Depression and Anxiety in Children With Cystic Fibrosis Based on the Patient Health Questionnaire-9 and Generalized Anxiety Disorder-7 in a Single Cystic Fibrosis Center. Journal of the American Academy of Child & Adolescent Psychiatry 57(10): S201-S202, 2018

International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety. Thorax 71(1): 26-34, 2016

Depression and anxiety in adolescents and adults with cystic fibrosis in the UK: a cross-sectional study. Journal of Cystic Fibrosis 13(6): 745-753, 2014

Symptoms of depression impact the course of lung function in adolescents and adults with cystic fibrosis. Bmc Pulmonary Medicine 14: 205, 2014

Screening of depression and anxiety symptoms in patients with cystic fibrosis and parent caregivers using international guidelines. Journal of Cystic Fibrosis 15: S114-S115, 2016

Associations between depression and anxiety symptoms and retinal vessel caliber in adolescents and young adults. Psychosomatic Medicine 76(9): 732-738, 2015

Condition-specific associations of symptoms of depression and anxiety in adolescents and young adults with asthma and food allergy. Journal of Asthma 53(3): 282-288, 2016

Online versus paper-based screening for depression and anxiety in adults with cystic fibrosis in Ireland: a cross-sectional exploratory study. Bmj Open 8(1): E019305, 2018

Long-term follow-up of cystic fibrosis newborn screening: psychosocial functioning of adolescents and young adults. Journal of Cystic Fibrosis 13(2): 227-234, 2014

Guided internet-administered self-help to reduce symptoms of anxiety and depression among adolescents and young adults diagnosed with cancer during adolescence (U-CARE: YoungCan): a study protocol for a feasibility trial. Bmj Open 7(1): E013906, 2017

Prevalence of symptoms of anxiety and depression in German patients with cystic fibrosis. Chest 138(4): 929-936, 2010

Parenting adolescents with cystic fibrosis: the adolescents' and young adults' perspectives. Patient Preference and Adherence 5: 563-570, 2011

Screening And Treating For Depression And Anxiety In Individuals With Cystic Fibrosis. Journal of the American Academy of Child & Adolescent Psychiatry 55(10): S302-S303, 2016